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The monitoring of patients, by themselves and their caregivers, is very important in the
prophylaxis of bipolar disorder. This study aimed to develop a Chinese-language version
of an instrument for assessment of manic and depressive symptoms by patients and their
families. Fifty-eight inpatients and outpatients with a DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders) diagnosis of bipolar disorder were recruited. All subjects
underwent clinical psychopathologic assessment by experienced psychiatrists using the
Young Mania Rating Scale (YMRS) and the Hamilton Depression Rating Scale (HDRS). At
the same time, each patient and key family members filled out the Chinese-language version
of the Internal State Scale (ISS) for monitoring mental symptoms. Patients were examined
a second time if they had entered remission or a new episode of the opposite polarity. The
ISS was divided into two subscales, of well-being/activation and of irritability. Patients’ well-
being/activation and irritability subscales were significantly correlated with YMRS scores
and the well-being/activation subscale was also significantly correlated with the HDRS score.
Family members’ irritability subscales were significantly correlated with HDRS scores only.
The reliability and constructive validity of the ISS was good in both patients with bipolar
disorder and their families.
Key Words: bipolar disorder, psychopathology, self-rating scale
(Kaohsiung J Med Sci 2003;19:170–6)
Received: September 6, 2002 Accepted: March 4, 2003
Address correspondence and reprint requests to: Dr. Yen-
Kuang Yang, Department of Psychiatry, National Cheng Kung
University Medical College and Hospital, 138 Sheng Li Road,
Tainan 704, Taiwan.
E-mail: ykyang@mail.ncku.edu.tw
When Emil Kraepelin distinguished patients with
manic-depressive psychosis from those with dementia
praecox in 1899 [1], bipolar disorder was characterized
as a disease with little functional deterioration that
tended to relapse. The course of recurrent bipolar
disorders is now divided into bipolar I disorder, bipolar
II disorder, cyclothymic disorder, and bipolar disorder
not otherwise specified (longitudinal course, seasonal
pattern, rapid cycling). Patients may have between
two and 30 manic episodes during their lifetime (mean,
9 episodes). About 40% of all patients have more than
10 episodes, 45% have more than one episode, and 40%
have a chronic disorder [2,3]. Scott proposed that an
adult developing bipolar disorder in his or her mid-
20s effectively loses 9 years of life, 12 years of normal
health, and 14 years of working life [4]. Although
drugs such as lithium provide effective prophylaxis
[5], their efficacy appears to be less than expected.
Solomon et al pointed out that more recent studies of
prophylactic drugs report that about 50% of bipolar
patients relapse within 2 years [6]. Several side effects
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of these drugs have decreased patient compliance and
increased the load on caregivers, encouraging the use
of alternative drug strategies and the development of
psychotherapies specific to this disorder.
Descriptions of the core characteristics of bipolar
disorder often emphasize the euphoric state that is the
affective opposite of depression [1]. However, there is
some evidence that euphoric mood is not the core
manic symptom. Goodwin and Jamison indicate that
depressive and irritable symptoms are more common
than euphoric symptoms in the manic phase, occurring
in 70–80% of patients [2]. We hypothesized that mania,
depression, and irritability constitute the core
characteristics of bipolar disorder.
The characteristic mood swings in patients with
bipolar disorder impair social function, work
performance, and even cognitive function [3,6]. Hence,
monitoring patients’ psychopathology, particularly
in patient self-reports, plays an important role in the
diagnosis and long-term follow-up of mood disorders
[7]. Most tools used to assess the symptomatology of
bipolar disorder are observer-rated, based on either a
brief interview [8–10], extended patient observation
[11,12], or both [13]. There are few tools, such as the
Internal State Scale (ISS) [7] and the Self-Report Manic
Inventory [14], for self-rating. In addition, caregivers
play an important role in caring for patients with
mental problems in Taiwan [15]. However, there is no
rat ing scale  for  caregivers  to  help monitor
symptomatology in bipolar patients.
Although the relative paucity of self-report manic
scales may reflect an assumption that manic patients
are unreliable due to their mood state, the ISS is a valid
measure of the severity of manic/hypomanic
symptoms and the sensitivity of the mood fluctuation.
The ISS is easily used by subjects and requires 5–10
minutes to complete [7]. ISS is widely applicable in
various conditions, such as when a trained rater is not
available and mania is not present. It provides
information on mood fluctuations and reduces the
costs of regular evaluation. However, to maintain
compliance, patients and their families need to be
reminded regularly, during outpatient clinic visits, to
fill out the form [16]. In our study, visiting durations
were between 2 weeks and 1 month.
The goal of this study was to develop a Chinese-
language rating tool for both patients and families.
The scale would potentially offer subscales to reflect
the presence and severity of manic and depressive
symptoms. The scale would be a convenient and
inexpensive way to monitor mood fluctuations or
disease relapse. In addition, we hope the scale will
provide a better strategy for long-term follow-up of
patients with bipolar disorder.
PATIENTS AND METHODS
Subjects
Patients were drawn from the inpatient and outpatient
units of a university hospital in southern Taiwan.
These patients met DSM-IV criteria for a current
episode of major depression, mania, or hypomania.
Before the assessment was performed, informed
consent was obtained from the patients and their
families. Fifty-eight patients with bipolar disorder
(34.10 ± 16.30 years old; 28 males and 30 females), 74
healthy controls (19.25 ± 3.18 years old; 40 males and
34 females) from a high school, and 58 caregivers (18
males and 40 females) completed the ISS. Of the
caregivers, 41.8% were the patients’ parents, 28% were
siblings, and 15% were the patients’ partners or
spouses; 57.8% of patients received at least high-school
education, and only 25.9% of patients were married.
The definition of a key caregiver was someone who
lived with the patient, was entitled to decide treatment
mode and medication, and was responsible for the
patient’s daily care. Patients were excluded from the
study if they had known substance intoxication or
withdrawal, a history of organic brain syndromes, a
neurologic disorder, or a history of treatment with
electric convulsive therapy. All subjects gave informed
consent.
Scales
The Chinese-language version of the ISS was translated
from the original with the permission of Dr. Mark S.
Bauer [7]. The translation was first done by a
psychiatrist, and then back-translated for comparison.
Five items were added to the original 16 items, yielding
21 in total. The ISS was originally designed for patient
use as a means to sample self-perception (ISS-P). We
developed a family version to include the key caregiver
(ISS-F) and added five items to the 16 in order to
develop a more ideal assessment tool, not only for the
patient’s self-rating but also for the key caregiver’s
rating. The 21 items were presented as a 100 mm visual
analog-line format; the last item was a global index for
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the current mood.
The Hamilton Depression Rating Scale (HDRS) is
an itemized questionnaire providing information on
the cognitive and somatic symptoms of depression,
and is rated by psychiatrists [17]. The Hamilton Anxiety
Rating Scale (HARS) is an itemized questionnaire
providing information on the cognitive and somatic
symptoms of anxiety, and is also rated by psychiatrists.
The inter-rater reliability, r, of HARS is 0.88, and that
of HDRS is 0.93. The Young Mania Rating Scale (YMRS)
is also rated by psychiatrists [10].
Evaluation procedures
Patients filled out the ISS-P and within 24 hours
underwent a clinical interview to establish the episode
and clinical diagnosis. The interviewer was blinded to
the ISS results. Symptom severity was assessed using
HDRS and YMRS. The caregiver also filled out an ISS-
F within 24 hours after the patient had been assessed.
Patients were evaluated on an additional occasion if
they were determined to have entered remission, which
was defined as an HDRS score of less than 7, or if they
had a YMRS score of less than 5 or had experienced
another episode. Twelve of 58 patients and their key
caregivers filled out an ISS every month for at least 6
months, at the outpatient clinic or at their homes. The
r values of test-retest reliability 2 weeks later, using 20
patients and healthy controls recruited from the
community, were 0.81 and 0.91, respectively.
Statistical analysis
All analyses were carried out using the SPSS statistical
software package (SPSS, Inc., Chicago, IL, USA) for
Windows. Statistical analysis included Chi-squared
and independent t-tests. Principal component analysis
and Oblimin with Kaiser normalization rotation were
used for factor analysis. Statistically significant
differences were shown among the groups at p values
of less than 0.05.
RESULTS
Principal component analysis identified three factors
with Eigenvalues greater than 1.0 (Table 1). The nine
items of factor 1 composed the activation subscale, the
eight items of factor 2 composed the irritability
subscale, and the three items of factor 3 composed the
Table 1. Factor loading from principal components analysis
Item Factor 1 Factor 2 Factor 3
Today...
I feel energized 0.817 0.250 0.397
I feel overactive 0.813 0.351 0.477
I feel like having new ideas and plans 0.793 0.430 0.450
I feel “sped up” inside 0.793 0.497 0.360
I feel like going on a buying spree 0.746 0.456 0.135
My thoughts are going fast 0.745 0.359 0.539
I feel argumentative 0.679 0.610 0.317
I feel less need for sleep 0.671 0.357 0.192
I feel talkative 0.670 0.409 0.196
I feel depressed 0.325 0.809 0.217
I feel impulsive 0.447 0.771 0.291
I feel restless 0.448 0.771
I feel like the world is against me 0.499 0.763
I feel irritable 0.399 0.763 0.337
I cannot concentrate 0.436 0.746
My mood is changeable 0.444 0.690 0.248
It seems like nothing will ever work out for me 0.266 0.673 0.137
I feel like a capable person 0.605 0.332 0.803
I actually feel greater inside 0.522 0.441 0.763
I feel like people are out to get me 0.578 0.413 0.746
Initial Eigenvalues 8.944 2.331 1.053
Extraction method: principal component analysis. Rotation method: Oblimin with Kaiser normalization.
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well-being subscale (Table 2). Since the three items of
factor 3, i.e. “I feel like a capable person”, “I feel like
people are out to get me”, and “I actually feel greater
inside”, were highly associated with the other items of
factor 1, they were added together to comprise one
symptom dimension, the well-being/activation index.
The α coefficient for the reliability of internal consistency
was 0.92 for the well-being/activation index and 0.89
for the irritability index.
The correlations among the subscales of the ISS and
other rating scales related to mood swing monitoring
are shown in Table 3. Patients’ well-being/activation
scores were significantly correlated with YMRS scores
(r = 0.57, p < 0.01), but they were significantly negatively
correlated with HDRS scores (r = –0.30, p < 0.01).
Patients’ irritability scores were significantly correlated
with YMRS scores (r = 0.26, p < 0.05). Global index
scores for current mood were significantly negatively
associated with HDRS scores (r = –0.30, p < 0.05).
Families’ well-being/activation scores were not
significantly correlated to YMRS or HDRS, but families’
irritability scores were significantly correlated with
HDRS scores (r = 0.28, p < 0.05). The single items of the
ISS-F that were correlated to YMRS scores were
“irritable” (item 2) (r = 0.29, p < 0.05), “out to get me”
(item 4) (r = 0.28, p < 0.05), “less need of sleep” (item
16) (r = 0.28, p < 0.05), and “buying spree” (item 19)
(r = 0.28, p < 0.05). The single items of the ISS-F that
were correlated to HDRS score were “depressed” (item
7) (r = 0.37, p < 0.01), “sped up” (item 12) (r = 0.32, p <
0.05), “restless” (item 13) (r = 0.39, p < 0.01), and “being
unable to concentrate” (item 20) (r = 0.31, p < 0.05).
DISCUSSION
Although this scale was adapted from the original ISS,
there were still some differences between the items on
the two scales. In the current study, the items “I feel
argumentative” and “I feel like people are out to get
me” were no longer defined as part of the irritability
index. This may be due to cultural differences in manic
symptomatology and perception of the expression of
items. The different demographic variables in the
current study and the original ISS study need to be
further explored.
The global index for mood was the last item on the
scale, with a 100 mm visual analog-line record ranging
Table 2. Subscales after factor analysis on the Internal State Scale
Item no. Symptom dimension Loading
Well-being/activation index
8 My thoughts are going fast (W) 0.745
10 I feel overactive (W) 0.813
12 I feel “sped up” inside (W) 0.793
14 I feel argumentative (W) 0.679
15 I feel energized (W) 0.817
16 I feel less need for sleep (W) 0.671
17 I feel like having new ideas and plans (W) 0.793
18 I feel talkative (W) 0.670
19 I feel like going on a buying spree (W) 0.746
3 I feel like a capable person (A) 0.803
4 I feel like people are out to get me (A) 0.746
5 I actually feel greater inside (A) 0.763
Irritability index
1 I feel energized (I) 0.690
2 I feel irritable (I) 0.763
6 I feel impulsive (I) 0.771
7 I feel depressed (I) 0.809
9 It seems like nothing will ever work out for me (I) 0.673
11 I feel like the world is against me (I) 0.763
13 I feel restless (I) 0.771
20 I cannot concentrate (I) 0.746
A = activation; I = irritability; W = well-being.
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from depression to elation, and was used for patients
to self-monitor mood shifts. However, it failed to
correlate with other indices, such as YMRS and HDRS
scores, so was less useful in this study than it is in
Western countries [7]. There are some differences
between the Chinese-language version of the ISS and
the original. The Chinese version had different
subscales from the original but had higher correlations
of symptom severity.
From the perspective of the significant correlations
found among symptom severities, using an objective
rating, the results of this study support the constructed
validity of the ISS. However, since only a few cases
demonstrated the predictive validity of the ISS, further
extensive longitudinal exploration of mood shifts and
predicted validity is required.
Our original intent was for the scale to be used not
only by patients but also by their families. Although
the original ISS was primarily designed to assess self-
perception of internal moods rather than behavior
patterns, we added some behavioral observation items
to the family version. However, the family version
still suffered from poor sensitivity and validity. Many
factors may confound the sensitivity and validity in
the family version. First, family members may have
limited ability to observe symptoms and may record
them in an inadequate range of items. Second, the
construction of the rating scale in the family version
Table 3. Correlation among different scales
Well-being/ Irritability Global HDRS YMRS Well-being/ Irritability Global
activation index* index of activation index† index of
index* current mood* index† current mood†
Well-being/ 0.658‡ 0.455‡ –0.297§ 0.571‡ 0.475‡ 0.450‡ 0.328‡
activation index*
Irritability index* 0.658‡ 0.139 0.064 0.261§ 0.330‡ 0.509‡ 0.203§
Global index of 0.455‡ 0.139 –0.298§ 0.214 0.343‡ 0.187§ 0.359‡
current mood*
HDRS –0.297§ 0.064 –0.298§ –0.206 0.065 0.283§ –0.213
YMRS 0.571‡ 0.261§ 0.214 –0.206 0.236 0.194 0.172
Well-being/ 0.475‡ 0.330‡ 0.343‡ 0.065 0.236 0.767‡ 0.461‡
activation index†
Irritability index† 0.450‡ 0.509‡ 0.187§ 0.283§ 0.194 0.767‡ 0.322‡
Global index of
current mood† 0.328‡ 0.203§ 0.359‡ –0.213 0.172 0.461‡ 0.322‡
Well-being/activation index includes items 3, 4, 5, 8, 10, 12, 14, 15, 16, 17, 18, 19. Irritability index includes items 1, 2, 6, 7, 9, 11, 13, 20. HDRS
= Hamilton Depression Rating Scale; YMRS = Young Mania Rating Scale. *Patient; †caregiver. ‡p = 0.01 (2-tailed); §p = 0.05 (2-tailed).
may be completely different from that in the patient
version. We need to further compare families after
group education, and develop a validated version for
the early detection of relapse. For caregivers, we
suggest using this present version and emphasize that
certain items correlate with the YMRS (items 2, 4, 16,
and 19) and the HDRS (items 7, 12, 13, and 20).
The results of the present study need to be
interpreted with caution. First, the study only included
a small number of patients, so the multiple comparisons
among different scales will increase type I errors.
Second, a prospective study is needed to test the
predictive validity of ISS in both versions. Third, the
control group had different demographics (age and
sex), which may influence the sensitivity of mood
change and factor analysis of subscales and needs
further study with a large-scale sample;  the
interpretation of the factor analysis needs to be
cautious. Finally, further observation of possible
symptomatology differences in bipolar disorder in
Chinese is necessary.
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